Solanki A, Zheng K, Skipworth A, Robin L, Leparski R, Henry E
Curr Oncol. 2024; 31(8):4781-4794.
PMID: 39195341
PMC: 11353739.
DOI: 10.3390/curroncol31080358.
Ghali F, Holt S, Koehne E, Chen J, Weg E, Liao J
Front Oncol. 2024; 14:1341655.
PMID: 38812783
PMC: 11133586.
DOI: 10.3389/fonc.2024.1341655.
Riveros C, Ranganathan S, Haque W, Huang E, Xu J, Kulkarni G
Can Urol Assoc J. 2023; 18(2):17-24.
PMID: 37931278
PMC: 10841558.
DOI: 10.5489/cuaj.8386.
Dyrskjot L, Hansel D, Efstathiou J, Knowles M, Galsky M, Teoh J
Nat Rev Dis Primers. 2023; 9(1):58.
PMID: 37884563
PMC: 11218610.
DOI: 10.1038/s41572-023-00468-9.
Kamran S, Zhou Y, Otani K, Drumm M, Otani Y, Wu S
Clin Cancer Res. 2023; 29(24):5116-5127.
PMID: 37870965
PMC: 10722135.
DOI: 10.1158/1078-0432.CCR-23-0792.
[Radical cystectomy or trimodal therapy for bladder cancer: where do we stand?].
Rodel C
Urologie. 2023; 62(10):1088-1089.
PMID: 37670162
DOI: 10.1007/s00120-023-02194-2.
[Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer].
Fleischmann M, Rodel C
Strahlenther Onkol. 2023; 199(9):871-873.
PMID: 37532957
PMC: 10449683.
DOI: 10.1007/s00066-023-02134-1.
Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives.
Fan X, He W, Huang J
Transl Androl Urol. 2023; 12(5):802-808.
PMID: 37305635
PMC: 10251081.
DOI: 10.21037/tau-23-124.
Muscle invasive bladder cancer and radical cystectomy: a risk predictive model.
Tfaily M, Tamim H, Hajj A, Mukherji D
Ecancermedicalscience. 2022; 16:1456.
PMID: 36405942
PMC: 9666275.
DOI: 10.3332/ecancer.2022.1456.
Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis.
Qiu J, Zhang H, Xu D, Li L, Xu L, Jiang Y
J Oncol. 2022; 2022:7306198.
PMID: 35607328
PMC: 9124076.
DOI: 10.1155/2022/7306198.
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.
Sung H, Kim H, Kim R, Kim C, Kwon G, Park W
Investig Clin Urol. 2022; 63(2):168-174.
PMID: 35244990
PMC: 8902424.
DOI: 10.4111/icu.20210407.
Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation model.
Magee D, Cheung D, Hird A, Sridhar S, Catton C, Chung P
Can Urol Assoc J. 2021; 16(4):E197-E204.
PMID: 34812723
PMC: 9054325.
DOI: 10.5489/cuaj.7453.
MR-Guided Adaptive Radiotherapy for Bladder Cancer.
Hijab A, Tocco B, Hanson I, Meijer H, Nyborg C, Bertelsen A
Front Oncol. 2021; 11:637591.
PMID: 33718230
PMC: 7947660.
DOI: 10.3389/fonc.2021.637591.
Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT.
Pickard R, Goulao B, Carnell S, Shen J, MacLennan G, Norrie J
Health Technol Assess. 2020; 24(61):1-110.
PMID: 33228846
PMC: 7750862.
DOI: 10.3310/hta24610.
Trimodal therapy in T2-4aN0M0 bladder cancer--How to select the best candidate?.
Gofrit O, Meirovitz A, Frank S, Rabinovich I, Luwisch H, Yutkin V
Cancer Med. 2020; 9(22):8491-8497.
PMID: 32960495
PMC: 7666756.
DOI: 10.1002/cam4.3478.
Outcomes of patients undergoing radiation therapy for bladder cancer.
Hasan S, Galvan E, Shaver C, Hermans M, Ha C, Swanson G
Bladder (San Franc). 2020; 5(4):e37.
PMID: 32775479
PMC: 7401990.
DOI: 10.14440/bladder.2018.785.
Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysis.
Wilhite T, Routman D, Arnett A, Glasgow A, Habermann E, Pisansky T
Bladder (San Franc). 2020; 5(3):e34.
PMID: 32775476
PMC: 7401988.
DOI: 10.14440/bladder.2018.639.
Will chemoradiation-based bladder-sparing therapy become a standard of care for muscle-invasive bladder cancer?.
Koga F
Transl Androl Urol. 2020; 9(3):981-982.
PMID: 32676378
PMC: 7354303.
DOI: 10.21037/tau-20-837.
The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trial.
Lewis R, Todd R, Newton M, Jones R, Wilson C, Donovan J
Trials. 2020; 21(1):629.
PMID: 32641097
PMC: 7346417.
DOI: 10.1186/s13063-020-04559-w.
Bladder preservation in muscle-invasive bladder cancer: a comprehensive review.
Hamad J, McCloskey H, Milowsky M, Royce T, Smith A
Int Braz J Urol. 2020; 46(2):169-184.
PMID: 31961624
PMC: 7025842.
DOI: 10.1590/S1677-5538.IBJU.2020.99.01.
